NCT01382329 - H5N1 Vaccine Study in Japanese Adults | Biotech Hunter

Enrollment

340

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

August 31, 2011

Study Completion Date

May 31, 2012

Conditions

H5N1 Influenza

Interventions

BIOLOGICAL

H5N1 (pre-)pandemic influenza vaccine (whole virion, Vero Cell derived, inactivated)

Intramuscular injection into the musculus deltoideus or subcutaneous injection in the upper arm

Trial Locations (3)

Medical Co. LTA PS Clinic, Fukuoka

CPC Clinic, Medipolis Medical Research Institute, Kagoshima

Osaka Pharmacology Clinical Research Hospital, Osaka